EMANUELLI, Giorgio
EMANUELLI, Giorgio
Dip. FISIOPATOLOGIA CLINICA (attivo dal 01/01/1900 al 30/04/2013)
[Physiopathological mechanisms in the natural history of the atherosclerotic plaque]
1995-01-01 MONTRUCCHIO G ;EMANUELLI G ;ORZAN F ;CAMUSSI G ;BRUSCA A ;BATTAGLIA CL ;LUPIA E ;PUCCI A
[The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects]
2003-01-01 Bellone G; Tibaudi D; Carbone A; Smirne C; Busso V; Ferrero I; Bosco O; Gramigni C; Segir R; Pagano M; Camandona M; Nano M; Palestro G; Dei Poli M; Emanuelli G
A Xenogenic Bone Derivative as a Potential Adjuvant for Bone Regeneration and Implant Osseointegration: An In Vitro Study
2017-01-01 Bellone G.; Vizio B.; Scirelli T.; Emanuelli G.
Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential
2001-01-01 Bellone G; Carbone A; Sibona N; Bosco O; Tibaudi D; Smirne C; Martone T; Gramigni C; Camandona M; Emanuelli G; Rodeck U.
Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitis
2004-01-01 LUPIA E; GOFFI A; DE GIULI P; AZZOLINO O; BOSCO O; PATRUCCO E; VIVALDO MC; RICCA M; WYMANN MP; HIRSCH E; MONTRUCCHIO G; EMANUELLI G
Antagonistic interactions between gemcitabineand 5-fluorouracil in the human pancreatic carcinoma cell line
2006-01-01 Bellone G; Carbone A; Busso V; Scirelli T; Buffolino A; Smirne C; Novarino A; Bertetto O; Tosetti L; Emanuelli G
Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients
2000-01-01 Bellone G; Rollino C; Borsa S; Ferrero I; Martina G; Carbone A; Mareschi K; Quarello F; Piccoli G; Emanuelli G; Matera L.
Biological aspects ofpancreatic cancer
2005-01-01 Tonel E; Carbone A; Scirelli T; Bellone G; Emanuelli G.
Bone marrow stroma-derived prolactin isinvolved in basal and platelet-activating factor-stimulated in vitroerythropoiesis
1997-01-01 Bellone G; Astarita P; Artusio E; Silvestri S; Mareschi K; Turletti A; Buttiglieri S; Emanuelli G; Matera L.
Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist.
1986-01-01 Montrucchio G; Alloatti G; Mariano F; Tetta C; Emanuelli G; Camussi G.
Circulating vascular endothelial growth factor andinterferon-gamma-inducible protein-10 levels in pancreatic cancer duringchemotherapy
2005-01-01 Bellone G; Novarino A; Chiappino I; Gramigni C; Carbone A; Addeo A; Tonel E; Bertetto O; Emanuelli G.
Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells. Head Neck
2004-01-01 Martone T; Bellone G; Pagano M; Beatrice F; Palonta F; Emanuelli G; Cortesina G.
Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted bypancreatic carcinoma cells.
2006-01-01 Bellone G; Carbone A; Smirne C; Scirelli T; Buffolino A; Novarino A; Stacchini A; Bertetto O; Palestro G; Sorio C; Scarpa A; Emanuelli G; Rodeck U.
Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival
2006-01-01 BELLONE G; SMIRNE C; MAURI FA; TONEL E; CARBONE A; BUFFOLINO A; DUGHERA L; ROBECCHI A; PIRISI M; EMANUELLI G
Decreased expression of stem cell factor in esophageal and gastric mucosa after esophagogastric anastomosis for cancer: potential relevance to motility.
2003-01-01 NANO M; BATTAGLIA E; G. GASPARRI; DUGHERA L; CASALEGNO PA; BELLONE G; TIBAUDI D; GRAMIGNI C; FERRONATO M; CHIUSA L; NAVINO M; SOLEJ M; DEI POLI M; EMANUELLI G
Differential expression of transforming growth factors-beta1, -beta2 and -beta3in human colon carcinoma.
2001-01-01 Bellone G; Carbone A; Tibaudi D; Mauri F; Ferrero I; Smirne C; Suman F; Rivetti C; Migliaretti G; Camandona M; Palestro G; Emanuelli G; Rodeck U.
Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease
1999-01-01 BATTAGLIA E.; BIANCONE L; RESEGOTTI A; EMANUELLI G; FRONDA GR.; G. CAMUSSI
Expression of CD40 and its ligand, CD40L, in intestinalExpression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease.
1999-01-01 BATTAGLIA E ;BIANCONE L ;RESEGOTTI A ;EMANUELLI G ;FRONDA GR ;CAMUSSI G
Expression oftransforming growth factor-beta isoforms in the skin, kidney, pancreas andbladder in a German shepherd dog affected by renal cystadenocarcinoma and nodulardermatofibrosis
2003-01-01 Vercelli A; Bellone G; Abate O; Emanuelli G; Cagnasso A.
Growth stimulation of colorectal carcinomacells via the c-kit receptor is inhibited by TGF-beta 1
1997-01-01 Bellone G; Silvestri S; Artusio E; Tibaudi D; Turletti A; Geuna M; Giachino C; Valente G; Emanuelli G; Rodeck U.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| [Physiopathological mechanisms in the natural history of the atherosclerotic plaque] | 1995 | MONTRUCCHIO G ;EMANUELLI G ;ORZAN F ;CAMUSSI G ;BRUSCA A ;BATTAGLIA CL ;LUPIA E ;PUCCI A | |
| [The c-kit/Stem Cell Factor in the cancerogenetic process of colon-rectal carcinoma. Biological and clinical aspects] | 2003 | Bellone G; Tibaudi D; Carbone A; Smirne C; Busso V; Ferrero I; Bosco O; Gramigni C; Segir R; Pagano M; Camandona M; Nano M; Palestro G; Dei Poli M; Emanuelli G | |
| A Xenogenic Bone Derivative as a Potential Adjuvant for Bone Regeneration and Implant Osseointegration: An In Vitro Study | 2017 | Bellone G.; Vizio B.; Scirelli T.; Emanuelli G. | |
| Aberrant activation of c-kit protects colon carcinoma cells against apoptosis and enhances their invasive potential | 2001 | Bellone G; Carbone A; Sibona N; Bosco O; Tibaudi D; Smirne C; Martone T; Gramigni C; Camandona M; Emanuelli G; Rodeck U. | |
| Ablation of phosphoinositide 3-kinase-gamma reduces the severity of acute pancreatitis | 2004 | LUPIA E; GOFFI A; DE GIULI P; AZZOLINO O; BOSCO O; PATRUCCO E; VIVALDO MC; RICCA M; WYMANN MP; HIRSCH E; MONTRUCCHIO G; EMANUELLI G | |
| Antagonistic interactions between gemcitabineand 5-fluorouracil in the human pancreatic carcinoma cell line | 2006 | Bellone G; Carbone A; Busso V; Scirelli T; Buffolino A; Smirne C; Novarino A; Bertetto O; Tosetti L; Emanuelli G | |
| Association between elevated prolactin levels and circulating erythroid precursors in dialyzed patients | 2000 | Bellone G; Rollino C; Borsa S; Ferrero I; Martina G; Carbone A; Mareschi K; Quarello F; Piccoli G; Emanuelli G; Matera L. | |
| Biological aspects ofpancreatic cancer | 2005 | Tonel E; Carbone A; Scirelli T; Bellone G; Emanuelli G. | |
| Bone marrow stroma-derived prolactin isinvolved in basal and platelet-activating factor-stimulated in vitroerythropoiesis | 1997 | Bellone G; Astarita P; Artusio E; Silvestri S; Mareschi K; Turletti A; Buttiglieri S; Emanuelli G; Matera L. | |
| Cardiovascular alterations in the rabbit infused with platelet activating factor (PAF): effect of kadsurenone, a PAF-receptor antagonist. | 1986 | Montrucchio G; Alloatti G; Mariano F; Tetta C; Emanuelli G; Camussi G. | |
| Circulating vascular endothelial growth factor andinterferon-gamma-inducible protein-10 levels in pancreatic cancer duringchemotherapy | 2005 | Bellone G; Novarino A; Chiappino I; Gramigni C; Carbone A; Addeo A; Tonel E; Bertetto O; Emanuelli G. | |
| Constitutive expression of interleukin-18 in head and neck squamous carcinoma cells. Head Neck | 2004 | Martone T; Bellone G; Pagano M; Beatrice F; Palonta F; Emanuelli G; Cortesina G. | |
| Cooperative induction of a tolerogenic dendritic cell phenotype by cytokines secreted bypancreatic carcinoma cells. | 2006 | Bellone G; Carbone A; Smirne C; Scirelli T; Buffolino A; Novarino A; Stacchini A; Bertetto O; Palestro G; Sorio C; Scarpa A; Emanuelli G; Rodeck U. | |
| Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival | 2006 | BELLONE G; SMIRNE C; MAURI FA; TONEL E; CARBONE A; BUFFOLINO A; DUGHERA L; ROBECCHI A; PIRISI M; EMANUELLI G | |
| Decreased expression of stem cell factor in esophageal and gastric mucosa after esophagogastric anastomosis for cancer: potential relevance to motility. | 2003 | NANO M; BATTAGLIA E; G. GASPARRI; DUGHERA L; CASALEGNO PA; BELLONE G; TIBAUDI D; GRAMIGNI C; FERRONATO M; CHIUSA L; NAVINO M; SOLEJ M; DEI POLI M; EMANUELLI G | |
| Differential expression of transforming growth factors-beta1, -beta2 and -beta3in human colon carcinoma. | 2001 | Bellone G; Carbone A; Tibaudi D; Mauri F; Ferrero I; Smirne C; Suman F; Rivetti C; Migliaretti G; Camandona M; Palestro G; Emanuelli G; Rodeck U. | |
| Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease | 1999 | BATTAGLIA E.; BIANCONE L; RESEGOTTI A; EMANUELLI G; FRONDA GR.; G. CAMUSSI | |
| Expression of CD40 and its ligand, CD40L, in intestinalExpression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease. | 1999 | BATTAGLIA E ;BIANCONE L ;RESEGOTTI A ;EMANUELLI G ;FRONDA GR ;CAMUSSI G | |
| Expression oftransforming growth factor-beta isoforms in the skin, kidney, pancreas andbladder in a German shepherd dog affected by renal cystadenocarcinoma and nodulardermatofibrosis | 2003 | Vercelli A; Bellone G; Abate O; Emanuelli G; Cagnasso A. | |
| Growth stimulation of colorectal carcinomacells via the c-kit receptor is inhibited by TGF-beta 1 | 1997 | Bellone G; Silvestri S; Artusio E; Tibaudi D; Turletti A; Geuna M; Giachino C; Valente G; Emanuelli G; Rodeck U. |